Objective: To evaluate the effects of an IV, low-dose ketamine-diazepam combination used for short-duration chemical restraint on the results of clinicopathologic testing in cats and to assess its practicality and tolerance.
Design: Prospective case series.
Animals: 42 client-owned cats of various breeds, ages, and health status.